📰 Vcel News
Page 3 - Vcel News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Vcel. Real-time updates on events, politics, business and more.
September 5, 2023
Citigroup Inc. raised its position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 3.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 109,391 shares of the biotechnology company’s stock after buying an additional 4,088 shares during the period. Citigroup […]
August 21, 2023
StockNews.com assumed coverage on shares of Vericel (NASDAQ:VCEL – Free Report) in a research note published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Several other equities analysts have also commented on VCEL. Stephens upped their price target on Vericel from $39.00 to $42.00 in a research note on Thursday, […]
August 13, 2023
Ingalls & Snyder LLC lessened its stake in Vericel Co. (NASDAQ:VCEL – Free Report) by 12.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 23,851 shares of the biotechnology company’s stock after selling 3,350 shares during the period. Ingalls & […]
August 12, 2023
GW&K Investment Management LLC boosted its position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 7.6% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,419,534 shares of the biotechnology company’s stock after buying an additional 100,244 shares during the quarter. GW&K Investment […]
August 8, 2023
Vericel Co. (NASDAQ:VCEL – Free Report) – Equities researchers at HC Wainwright lowered their Q3 2023 earnings per share (EPS) estimates for shares of Vericel in a research report issued on Thursday, August 3rd. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will post earnings of ($0.14) per share for the quarter, […]
August 5, 2023
Vericel (NASDAQ:VCEL – Get Free Report) released its quarterly earnings results on Wednesday. The biotechnology company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.02, Briefing.com reports. The company had revenue of $45.92 million during the quarter, compared to the consensus estimate of $42.14 million. Vericel had […]
August 4, 2023
Summit Creek Advisors LLC raised its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 0.8% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 433,547 shares of the biotechnology company’s stock after acquiring an additional 3,567 shares during the […]
August 3, 2023
Vericel (NASDAQ:VCEL – Get Free Report) released its quarterly earnings data on Wednesday. The biotechnology company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.02, Briefing.com reports. The firm had revenue of $45.92 million during the quarter, compared to analysts’ expectations of $42.14 million. Vericel had a […]
July 21, 2023
Fisher Asset Management LLC reduced its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 1.4% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 1,735,140 shares of the biotechnology company’s stock after selling 25,382 shares during the quarter. Fisher Asset Management LLC owned approximately […]
July 17, 2023
Vericel Co. (NASDAQ:VCEL – Get Free Report) Director Robert L. Md Zerbe sold 1,000 shares of the stock in a transaction that occurred on Friday, July 14th. The stock was sold at an average price of $38.84, for a total value of $38,840.00. Following the sale, the director now owns 33,395 shares in the company, […]